ertapenem
Also known as (4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid, (1R,5S,6S,8R,2'S,4's)-2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid
Ertapenem, sold under the brand name Invanz, is a carbapenem antibiotic medication used for the treatment of infections of the abdomen, the lungs, the upper part of the female reproductive system, and the diabetic foot.
Key facts
- Drug.H
- 25
- Drug.N
- 3
- Drug.O
- 7
- Drug.S
- 1
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 461095141
- Drug.image
- Ertapenem skeletal structure.svg
- Drug.image_class
- skin-invert-image
- Drug.image2
- Ertapenem ball-and-stick model.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Invanz
- Drug.MedlinePlus
- a614001
- Drug.DailyMedID
~8 min read
Article
13 sectionsContents
- Medical uses
- Contraindications
- Side effects
- Overdose
- Interactions
- Pharmacology
- Mechanism of action
- Susceptible bacteria
- Resistance
- Pharmacokinetics
- Comparison with other antibiotics
- History
- References
Ertapenem, sold under the brand name Invanz, is a carbapenem antibiotic medication used for the treatment of infections of the abdomen, the lungs, the upper part of the female reproductive system, and the diabetic foot.
The most common side effects include diarrhoea, nausea, headache, and problems around the area where the medicine is infused. It can significantly reduce the concentrations of valproic acid, an anti-seizure medication, in the blood to the point where it loses its effectiveness.